Publications écrites

Publications écrites

Livret liberté alimentaire
 

2013

Revue:Diabetes and Metabolism

Références: Publication écrite

Date: 2 Septembre 2013

Titre: Telemedecine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?
Auteurs: S. Franca, S. Borot, O. Ronsin, J.-L. Quesada, D. Dardari, C. Fagour, E. Renard,A.-M. Leguerrier, C. Vigeral, F. Moreau, P. Winiszewski, A. Vambergue, H. Mosnier-Pudar,L. Kessler, S. Reffet, B. Guerci, L. Millot, S. Halimi, C. Thivolet, P.-Y. Benhamou, A. Penfornis, G. Charpentier, H. Hanaire

————————————————————
Revue:Diabetes Care

Références: Publication en ligne

Date: 29 Avril 2013

Titre: Quality of care of people with type 2 diabetes in eight european countries
Auteurs: M.A. Stone, G. Charpentier, K. Doggen, O. Kuss, U. Linblad, C. Kellner, J. Nolan, A. Pazderska, G. Rutten, M. Trento, K. Khunti

————————————————————

2012

Revue:Le concours médical

Références: Tome 134 N°6 Juin 2012

Date: Juin 2012

Titre: La télémédecine, outil du futur?
Auteurs: Sylvia Franc

————————————————————

2011

Revue:Diabetes & Metabolism

Références: 37(2011) S71-S77

Date: Mars 2011

Titre: Telemedicine: What more is needed for its integration in everyday life?
Auteurs: S. Franc, A. Daoudi, S. Mounier, B. Boucherie, H. Laroye, C. Peschard, D. Dardari, O. Juy, E. Requeda, L. Canipel, G. Charpentier

————————————————————

Revue:Diabetes Care

Références: 34(3):533-9

Date: Mars 2011

Titre: The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)
Auteurs: Charpentier, G., Benhamou, P. Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., Bosson, J. L., Penfornis, A On behalf of the TeleDiab Study Group

————————————————————

Revue: Diabète & Obésité

Références: vol. 6 – numéro 48

Date: Avril 2011

Titre: Quelle place pour la télémédecine dans le suivi du diabète ? Expériences et perspectives.

Auteurs: Dr Sylvia Franc, Dr Ahmed Daoudi, Steeve Mounier, Dr Béatrix Boucherie, Héloïse Laroye, Anne-Claire Coyne, Dr Barbara Neraud, Dr Dured Dardari, Dr Guillaume Charpentier

————————————————————

Revue: Sang Thrombose Vaisseaux

Références: Volume 23, Numéro 4, Avril 2011

Date: Avril 2011

Titre: Télémédecine et diabète : état de l’art et perspectives.

Auteurs: Sylvia Franc, Ahmed Daoudi, Steeve Mounier, Béatrix Boucherie, Héloïse Laroye, Anne-Claire Coyne, Barbara Néraud, Dured Dardari, Guillaume Charpentier.

————————————————————

2010

Revue: Biofutur

Références: Biofutur 316

Date: Décembre 2010

Titre: Télémédecine appliquée au diabète : où en est-on ?
Auteurs: S Franc

————————————————————

Revue:Diabetes Care

Références: 33(9): 1913-18

Date: Septembre 2010

Titre: Type 2 diabetes: can post-prandial BG excursion be predicted?
Auteurs: S Franc, D Dardari, C Peschard, J-P Riveline, M Biedzinski, B Boucherie, C Petit, E Requeda, F Mistretta, M Varoud-Vial, G Charpentier

————————————————————

Revue: Journal du DELF – Diabète Éducation de Langue Française

Références: VOLUME 20 – N° 3,

Date: Septembre 2010

Titre: La télémédecine en diabétologie: quelle évolution pour le métier d’infirmier ?
Auteurs: L. Canipel, P-Y. Benhamou, H. Laroye, S. Mounier, G. Charpentier

————————————————————

Revue: Brochure insulinothérapie fonctionnelle (IF) : Usages et Bénéfices

Références: Laboratoires Novo Nordisk Pharmaceutique S.A.S

Date: Juillet 2010

Titre: chapitres : insuline basale ; activité physique ; les études

Auteurs: S Franc

————————————————————

Revue: Equilibre 

Références: Equilibre 275 : pages 52-55

Date: mai-juin 2010

Titre: Adaptation des doses d’insuline dans le DT1 en cas d’activité physique » 

Auteurs: S Franc

————————————————————

Revue: Revue Médecine des maladies Métaboliques 
Références: Vol. 4 – N°3 ; p 274-286
Date: Mai 2010

Titre: La télémédecine appliquée au diabète : les résultats acquis et les perspectives a venir
Auteurs: S. Franc, D. Dardari, B. Boucherie, A. Daoudi, G. Charpentier

————————————————————

Revue: Médecine des maladies Métaboliques
Références: Mai 2010 – Vol. 4 – N°3

Titre: Évolution des pratiques pour les infirmiers 

Auteurs:  L. Canipel1, D. Durain2, P.-Y. Benhamou3, G. Charpentier4

————————————————————

Revue: www.thelancet.com 
Références: Vol 375

Date: 24 Avril 2010

Titre: Survival as a function of HbA1c in people with type 2 diabetes

Auteurs: Jean-Pierre Riveline, Ronan Roussel, Kamel Mohammedi

————————————————————

Revue: Diabetes Metab.

Références: [Epub ahead of print]

Date: 2010 Mar 18.

Titre: Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy.
Auteurs: Riveline JP, Franc S, Biedzinski M, Jollois FX, Messaoudi N, Lagarde F, Lormeau B, Pichard S, Varroud-Vial M, Deburge A, Dresco E, Charpentier G; for the Groupe Pompe Sud-Francilien.

————————————————————

Revue: Nat Genet.

Références: 42(2):105-16.Epub 2010 Jan 17.

Date:2010 Feb

Titre: New genetic loci implicated in fasting glucose
homeostasis and their impact on type 2 diabetes risk.

Auteurs: Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Mägi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, Franklin CS, Navarro P, Song K, Goel A, Perry JR, Egan JM, Lajunen T, Grarup N, Sparsø T, Doney A, Voight BF, Stringham HM, Li M, Kanoni S, Shrader P, Cavalcanti-Proença C, Kumari M, Qi L, Timpson NJ, Gieger C, Zabena C, Rocheleau G, Ingelsson E, An P, O’Connell J, Luan J, Elliott A, McCarroll SA, Payne F, Roccasecca RM, Pattou F, Sethupathy P, Ardlie K, Ariyurek Y, Balkau B, Barter P, Beilby JP, Ben-Shlomo Y, Benediktsson R, Bennett AJ, Bergmann S, Bochud M, Boerwinkle E, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Charpentier G, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Cornelis M, Crawford G, Crisponi L, Day IN, de Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Fox CS, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Groves CJ, Grundy S, Gwilliam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N, Han X, Hartikainen AL, Hassanali N, Hayward C, Heath SC, Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD, Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jørgensen T, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Lyssenko V, Mahley R, Mangino M, Manning AK, Martínez-Larrad MT, McAteer JB, McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Morken MA, Mukherjee S, Naitza S, Narisu N, Neville MJ, Oostra BA, Orrù M, Pakyz R, Palmer CN, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rathmann W, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Scott LJ, Seedorf U, Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tanaka T, Thorand B, Tichet J, Tönjes A, Tuomi T, Uitterlinden AG, van Dijk KW, van Hoek M, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Walters GB, Ward KL, Watkins H, Weedon MN, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zeggini E, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Hattersley AT, Silander K, Salomaa V, Smith GD, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Dedoussis GV, Serrano-Ríos M, Morris AD, Lind L, Palmer LJ, Hu FB, Franks PW, Ebrahim S, Marmot M, Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso M, Hansen T, Pedersen O, Pramstaller PP, Wichmann HE, Illig T, Rudan I, Wright AF, Stumvoll M, Campbell H, Wilson JF; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators, Bergman RN, Buchanan TA, Collins FS, Mohlke KL, Tuomilehto J, Valle TT, Altshuler D, Rotter JI, Siscovick DS, Penninx BW, Boomsma DI, Deloukas P, Spector TD, Frayling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K, van Duijn CM, Aulchenko YS, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vollenweider P, Peltonen L, Mooser V, Abecasis GR, Wareham NJ, Sladek R, Froguel P, Watanabe RM, Meigs JB, Groop L, Boehnke M, McCarthy MI, Florez JC, Barroso I.

————————————————————

Revue: Nat Genet.

Références: 42(2):142-8. Epub 2010 Jan 17.

Date: 2010 Feb

Titre: Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
Auteurs: Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johnson T, Grarup N, Boesgaard TW, Lecoeur C, Shrader P, O’Connell J, Ingelsson E, Couper DJ, Rice K, Song K, Andreasen CH, Dina C, Köttgen A, Le Bacquer O, Pattou F, Taneera J, Steinthorsdottir V, Rybin D, Ardlie K, Sampson M, Qi L, van Hoek M, Weedon MN, Aulchenko YS, Voight BF, Grallert H, Balkau B, Bergman RN, Bielinski SJ, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Böttcher Y, Brunner E, Buchanan TA, Bumpstead SJ, Cavalcanti-Proença C, Charpentier G, Chen YD, Chines PS, Collins FS, Cornelis M, J Crawford G, Delplanque J, Doney A, Egan JM, Erdos MR, Firmann M, Forouhi NG, Fox CS, Goodarzi MO, Graessler J, Hingorani A, Isomaa B, Jørgensen T, Kivimaki M, Kovacs P, Krohn K, Kumari M, Lauritzen T, Lévy-Marchal C, Mayor V, McAteer JB, Meyre D, Mitchell BD, Mohlke KL, Morken MA, Narisu N, Palmer CN, Pakyz R, Pascoe L, Payne F, Pearson D, Rathmann W, Sandbaek A, Sayer AA, Scott LJ, Sharp SJ, Sijbrands E, Singleton A, Siscovick DS, Smith NL, Sparsø T, Swift AJ, Syddall H, Thorleifsson G, Tönjes A, Tuomi T, Tuomilehto J, Valle TT, Waeber G, Walley A, Waterworth DM, Zeggini E, Zhao JH; GIANT consortium; MAGIC investigators, Illig T, Wichmann HE, Wilson JF, van Duijn C, Hu FB, Morris AD, Frayling TM, Hattersley AT, Thorsteinsdottir U, Stefansson K, Nilsson P, Syvänen AC, Shuldiner AR, Walker M, Bornstein SR, Schwarz P, Williams GH, Nathan DM, Kuusisto J, Laakso M, Cooper C, Marmot M, Ferrucci L, Mooser V, Stumvoll M, Loos RJ, Altshuler D, Psaty BM, Rotter JI, Boerwinkle E, Hansen T, Pedersen O, Florez JC, McCarthy MI, Boehnke M, Barroso I, Sladek R, Froguel P, Meigs JB, Groop L, Wareham NJ, Watanabe RM.

————————————————————

Revue: DIABET

Date: 6 January 2010
Titre: Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy

Auteurs: Jean-Pierre Riveline a,b, Sylvia Franc a,b, Magdalena Biedzinski a,b, Francois-Xavier Jollois c, Noura Messaoudi d, Fabrice Lagarde e, Boris Lormeauf, Sylvie Pichard g, Michel Varroud-Vial a,b, Anne Deburge h, E. Dresco i, Guillaume Charpentier a,b, for the Groupe Pompe Sud-Francilien

————————————————————

2009

Revue: Diabetes and Metabolism

Références: 35(6):463-8.

Date: 2009 Dec

Titre: Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients

Auteurs: S. Franc, D. Dardari, B. Boucherie, J.-P. Riveline, M. Biedzinski, C. Petit, E. Requeda, P. Leurent, M. Varroud-Vial, G. Hochberg, G. Charpentier

————————————————————

Revue: Diabetes Res Clin Pract.

Références: [Epub ahead of print] PubMed PMID: 19932517.

Date: 2009 Nov 20.

Titre: Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries.
Auteurs: Stone MA, Wilkinson JC, Charpentier G, Clochard N, Grassi G, Lindblad U,

Müller UA, Nolan J, Rutten GE, Khunti K; on behalf of the GUIDANCE Study Group.

————————————————————

Revue: Diabetes.

Références: 58(11):2687-97. Epub 2009 Aug 3.

Date: 2009 Nov

Titre: Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Auteurs: Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chèvre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, Riveline JP, Hadjadj S, Gallois Y, Czernichow S, Hercberg S, Kaakinen M, Wiesner S, Charpentier G, Lévy-Marchal C, Elliott P, Jarvelin MR, Horber F, Dina C, Pedersen O, Sladek R, Meyre D, Froguel P.

————————————————————

Revue: Nat Genet.

Références: 41(10):1110-5. Epub 2009 Sep 6. Erratum in: Nat Genet. 2009 Oct;41(10):1156.

Date: 2009 Oct

Titre: Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Auteurs: Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proença C, Bacot F, Balkau B, Belisle A, Borch-Johnsen K, Charpentier G, Dina C, Durand E, Elliott P, Hadjadj S, Järvelin MR, Laitinen J, Lauritzen T, Marre M, Mazur A, Meyre D, Montpetit A, Pisinger C, Posner B, Poulsen P, Pouta A, Prentki M, Ribel-Madsen R, Ruokonen A, Sandbaek A, Serre D, Tichet J, Vaxillaire M, Wojtaszewski JF, Vaag A, Hansen T, Polychronakos C, Pedersen O, Froguel P, Sladek R.

————————————————————

Revue: Diabetes Obes Metab.

Références: 11(9):844-54. Epub 2009 Jul 13

Date: 2009 Sep

Titre: Earlier triple therapy with pioglitazone in patients with type 2 diabetes.

Auteurs: Charpentier G, Halimi S; F-PIO-100 Study Investigators.

————————————————————

Revue: Nephrol Dial Transplant. <

Références: 24(9):2866-71. Epub 2009 Apr 23.

Date: 2009 Sep

Titre: Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system.

Auteurs: Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, Bauwens M, Caudwell V, Ragot S, Bridoux F, Charpentier G, Marechaud R, Hadjadj S.

————————————————————

Revue: J Clin Endocrinol Metab.

Références: 94(8):3025-30. Epub 2009 May 26.

Date: 2009 Aug

Titre: The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes.

Auteurs: Laloi-Michelin M, Meas T, Ambonville C, Bellanné-Chantelot C, Beaufils S, Massin P, Vialettes B, Gin H, Timsit J, Bauduceau B, Bernard L, Bertin E, Blickle JF, Cahen-Varsaux J, Cailleba A, Casanova S, Cathebras P, Charpentier G, Chedin P, Crea T, Delemer B, Dubois-Laforgue D, Duchemin F, Ducluzeau PH, Bouhanick B, Dusselier L, Gabreau T, Grimaldi A, Guerci B, Jacquin V, Kaloustian E, Larger E, Lecleire-Collet A, Lorenzini F, Louis J, Mausset J, Murat A, Nadler-Fluteau S, Olivier F, Paquis-Flucklinger V, Paris-Bockel D, Raynaud I, Reznik Y, Riveline JP, Schneebeli S, Sonnet E, Sola-Gazagnes A, Thomas JL, Trabulsi B, Virally M, Guillausseau PJ; Mitochondrial Diabetes French Study Group.

————————————————————

Revue: Diabetes.

Références: 58(6):1450-6.
Date: 2009 Jun

Titre: G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. 

Auteurs: Sparsø T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, Wegner L, Grarup N, Gjesing AP, Banasik K, Cavalcanti-Proença C, Marchand M, Vaxillaire M, Charpentier G, Jarvelin MR, Tichet J, Balkau B, Marre M, Lévy-Marchal C, Faerch K, Borch-Johnsen K, Jørgensen T, Madsbad S, Poulsen P, Vaag A, Dina C, Hansen T, Pedersen O, Froguel P

————————————————————

Revue: NEPHROL DIAL TRANSPLANT

Date: 9 Avril 2009
Titre: Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system

Auteurs: Jean-Pierre Riveline1, Julie Teynie2,3,4, Simohamed Belmouaz5,6,7, Sylvia Franc1, Dured Dardari1, Marc Bauwens5,6,7, Val´erie Caudwell8, St´ephanie Ragot9, Frank Bridoux5,6,7, Guillaume Charpentier1, Richard Marechaud2 and Samy Hadjadj2,3,4,9,10

————————————————————

Revue: BMC Med Genet.
Références: 13;10:13.

Date: 2009 Feb

Titre: Evaluating the association of common APOA2 variants with type 2 diabetes.

Auteurs: Duesing K, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

————————————————————

Revue: Nat Genet.
Références: 41(1):89-94
Date: 2009 Jan
Titre: A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Auteurs: Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, Sparsø T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chèvre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jørgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Lévy-Marchal C, Pattou F, Meyre D, Blakemore AI, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel 

2008

Revue: Diabetes & Metabolism 34 – www.sciencedirect.com

Date: 2008

Titre: Treatment of diabetes mellitus using an external insulin pump in clinical practice

Auteurs: N.Jeandidier,J.-P.Riveline, N.Tubiana-Rufi, A. Vambergue, B.Cartargi, V.Melki, G.Charpentier, B.Guerci

————————————————————

Revue: Diabetes & Metabolism 34 – www.sciencedirect.com

Date: 2008

Titre: Insuline-pump use in everyday practice: Data from an exhaustive regional registry in France

Auteurs: J.-P.Riveline, F.-X. Jollois, N.Messaoudi, S.Franc, F.Lagarde, B.Lormeau, D.Dresco, O.Dupuy, G. CHarpentier, For Group Pompe Sud-Francilien

————————————————————

Revue: Pharmacogenet Genomics.

Références: 18(11):967-75.

Date: 2008 Nov

Titre: Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose.

Auteurs: Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, Cavalcanti-Proença C, Efendic S, Ostenson CG, Brismar K, Charpentier G, Gustafsson JA, Froguel P, Dahlman-Wright K, Steffensen KR.

————————————————————

Revue: Diabetes Metab.

Références: 34(4 Pt 2):425-38.

Date: 2008 Sep

Titre: Treatment of diabetes mellitus using an external insulin pump in clinical practice.

Auteurs: Jeandidier N, Riveline JP, Tubiana-Rufi N, Vambergue A, Catargi B, Melki V, Charpentier G, Guerci B.

————————————————————

Revue: Diabetologia.

Références: 51(9):1664-1670.

Date: 2008 Sep

Titre: Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study.

Auteurs: Massin P, Dubois-Laforgue D, Meas T, Laloi-Michelin M, Gin H, Bauduceau B, Bellanné-Chantelot C, Bertin E, Blickle JF, Bouhanick B, Cahen-Varsaux J, Casanova S, Charpentier G, Chedin P, Dupuy O, Grimaldi A, Guerci B, Kaloustian E, Lecleire-Collet A, Lorenzini F, Murat A, Narbonne H, Olivier F, Paquis-Flucklinger V, Virally M, Vincenot M, Vialettes B, Timsit J, Guillausseau PJ; for the GEDIAM (Mitochondrial Diabetes French Study Group).

————————————————————

Revue: BMC Med Genet.

Références: 22; 9(1):45.

Date: 2008 May

Titre: The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.

Auteurs: Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P, Meyre D.

————————————————————

Revue: Diabetologia.

Références: 51(5):821-6.

Date: 2008 May

Titre: Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.

Auteurs: Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

————————————————————

Revue: PLoS ONE.

Références: 3(5):e2031.

Date: 2008 May 7

Titre: Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.

Auteurs: Cauchi S, Meyre D, Durand E, Proença C, Marre M, Hadjadj S, Choquet H, De Graeve F, Gaget S, Allegaert F, Delplanque J, Permutt MA, Wasson J, Blech I, Charpentier G, Balkau B, Vergnaud AC, Czernichow S, Patsch W, Chikri M, Glaser B, Sladek R, Froguel P.

————————————————————

Revue: Diabetes.

Date: 2008 Apr 22.

Titre: Evaluation of the Association of IGF2BP2 Variants with Type 2 Diabetes in French Caucasians.

Auteurs: Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

————————————————————

Revue: Diabetes.

Date: 2008 Mar 17;

Titre: A rare mutation in ABCC8/SUR1 leading to altered KATP channel activity and {beta}-cell glucose sensing is associated with type 2 diabetes mellitus in adults.

Auteurs: Tarasov AI, Nicolson T, Riveline JP, Taneja TK, Baldwin SA, Baldwin JM, Charpentier G, Gautier JF, Froguel P, Vaxillaire M, Rutter GA.

————————————————————

Revue: Diabetes Metab.

Date: 2008 Mar 4

Titre: Insulin-pump use in everyday practice: Data from an exhaustive regional registry in France.

Auteurs: Riveline JP, Jollois FX, Messaoudi N, Franc S, Lagarde F, Lormeau B, Charitanski D, Benoit A, Pichard S, Deburge A, Dresco E, Dupuy O, Charpentier G; For Groupe Pompe Sud-Francilien.

————————————————————

Revue: BMC Med Genet.

Références: 29;9:14.

Date: 2008 Feb

Titre: Evaluating the association of common PBX1 variants with type 2 diabetes.

Auteurs: Duesing K, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

————————————————————

Revue: Obesity (Silver Spring).

Références: 16(2):476-82.

Date: 2008 Feb

Titre: Effects of TCF7L2 polymorphisms on obesity in European populations.

Auteurs: Cauchi S, Choquet H, Gutiérrez-Aguilar R, Capel F, Grau K, Proença C, Dina C, Duval A, Balkau B, Marre M, Potoczna N, Langin D, Horber F, Sørensen TI, Charpentier G, Meyre D, Froguel P.

————————————————————

Revue: Diabetologia.

Références: 51(1):76-81.

Date: 2008 Jan

Titre: Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids.

Auteurs: Duesing K, Charpentier G, Marre M, Tichet J, Hercberg S, Froguel P, Gibson F.

————————————————————

Revue: Diabetes.

Références: 57(1):244-54.

Date: 2008 Jan

Titre: Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.

Auteurs: Vaxillaire M, Veslot J, Dina C, Proença C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre M, Meyre D, Balkau B, Froguel P; DESIR Study Group.

2007

Revue: Diabetes Obes Metab.

Date: 2007 Dec 17

Titre: Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes.

Auteurs: Louet JF, Smith SB, Gautier JF, Molokhia M, Virally ML, Kevorkian JP, Guillausseau PJ, Vexiau P, Charpentier G, German MS, Vaisse C, Urbanek M, Mauvais-Jarvis F.

————————————————————

Revue: Diabetes Metab.

Références: 33(5):372-8.

Date: 2007 Nov

Titre: Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes.

Auteurs: Gutierrez-Aguilar R, Benmezroua Y, Balkau B, Marre M, Helbecque N, Charpentier G, Polychronakos C, Sladek R, Froguel P, Neve B.

————————————————————

Revue: Diabetes

Date: 31 Octobre 2007

Titre: A rare mutation in ABCC8/SUR1 leading to altered KATP channel activity and ß-cell glucose sensing is associated with type 2 diabetes mellitus in adults

Auteurs: Tarasov, Andrei; Imperial College London, Cell Biology, Division of Medicine, Nicolson, Tamara; Imperial College London, Cell Biology, Division of Medicine, Riveline, Jean-Pierre; Sud-Francilien Hospital, Taneja, Tarvinder; Imperial College London, Cell Biology, Division of Medicine, Baldwin, Stephen; University of Leeds, Institute lof Membrane and Systems Biology, Baldwin, Jocelyn; University of Leeds, Institute lof Membrane and Systems Biology, Charpentier, Guillaume; Sud-Francilien Hospital, Gautier, Jean-Francois; Paris 7 University, Endocrinology and Diabetes, Froguel, Philippe; Imperial College London, Genomic Medicine, Vaxillaire, Martine; Pasteur Institute, Lille, UMR8090, Rutter, Guy; Imperial College London, Cell Biology, Division of Medicine

————————————————————

Revue: BMC Med Genet.

Références: 8(1):53

Date: 2007 Aug 9

Titre: Analysis of KLF transcription factor family gene variants in type 2 diabetes.

Auteurs: Gutierrez-Aguilar R, Benmezroua Y, Vaillant E, Balkau B, Marre M, Charpentier G, Sladek R, Froguel P, Neve B.

————————————————————

Revue: BMC Med Genet.

Références: 8:44

Date: 2007 Jul 7.

Titre: Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity.

Auteurs: Bouatia-Naji N, Vatin V, Lecoeur C, Heude B, Proenca C, Veslot J, Jouret B, Tichet J, Charpentier G, Marre M, Balkau B, Froguel P, Meyre D. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P.

————————————————————

Revue: Sang Thrombose,  Vaisseaux  

Références: 19 (6) : 1-6.

Date: 2007

Titre: Télémédecine et diabète

Auteurs: S Franc, D Dardari, J-P Riveline, G Charpentier

————————————————————

2006

Revue: Guardcontrol Diabetes Care

Date: 13 Mars 2006

Titre: IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 1 DIABETES USING REAL-TIME CONTINUOUS GLUCOSE MONITORING

Auteurs: Dorothee Deiss, MD1, Jan Bolinder, MD, PhD2, Jean-Pierre Riveline, MD3, Tadej Battelino, MD, PhD4, Emanuele Bosi, MD, PhD5, Nadia Tubiana-Rufi, MD6, David Kerr, MD7, and Moshe Phillip, MD, 8 for the GuardControl Study Group

————————————————————